17α-Hydroxyprogesterone Caproate and the Risk of Glucose Intolerance in Pregnancy: A Systematic Review and Meta-analysis

OBJECTIVE:To evaluate whether 17α-hydroxyprogesterone caproate use in preventing preterm birth increases the risk of gestational diabetes mellitus (GDM). DATA SOURCES:Electronic databases (MEDLINE, Scopus, ClinicalTrials.gov, PROSPERO, EMBASE, Scielo and the Cochrane Central Register of Controlled T...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Obstetrics and gynecology (New York. 1953) 2019-03, Vol.133 (3), p.468-475
Hauptverfasser:	Eke, Ahizechukwu C., Sheffield, Jeanne, Graham, Ernest M.
Format:	Artikel
Sprache:	eng
Schlagworte:	17 alpha-Hydroxyprogesterone Caproate - therapeutic use Diabetes, Gestational - epidemiology Female Glucose Intolerance - epidemiology Humans Pregnancy Premature Birth - prevention & control Progestins - therapeutic use
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!